Statistics for Arbutus Biopharma (id:7988 ABUS)

Valuation metrics

Market cap

665.12M

Enterprise value

534.61M

Trailing P/E (ttm)

-7.98

Forward P/E

-10.32

PEG ratio

-10.32

Price/Sales (ttm)

98.65

Price/Book (mrq)

6.22

Enterprise Value/Revenue

79.30

Enterprise Value/EBITDA

-6.93

Overview

Shares outstanding

189.49M

Float

136.22M

Shares short

6.54M

% Held by insiders

0.22%

% Held by institutions

0.54%

Average volume (10 days)

931.54K

Average volume (90 days)

Price summary

52-Week low

1.79

52-Week high

4.72

52-Week change

47.58%

Beta

1.92

50-Day moving average

3.90

200-Day moving average

3.38

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

November 04th, 2010

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

0.00%

Operating margin

-1,304.78%

Operational effectiveness

Return on assets

-32.83%

Return on equity

-67.81%

Income statement

Revenue (ttm)

0.04

Revenue per share (ttm)

0.04

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-77,140,000.00

Net income to common (ttm)

-76,700,000.00

Diluted EPS (ttm)

-0.43

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

127.79M

Total cash per share (mrq)

0.67

Total debt (mrq)

6.76M

Total Debt/Equity (mrq)

6.32

Current ratio (mrq)

701.70%

Book value per share (mrq)

0.56

Cash flow

Cash flow statement

-71,827,000.00

Levered free cash flow (LFCF)

-39,811,624.00